Invictus MD

Category Archives : Investor Relations

Invictus MD Outlines Growth of Production Capacity to Seize Cannabis Recreational Market

On March 28, 2017, Posted by , In Investor Relations, With Comments Off on Invictus MD Outlines Growth of Production Capacity to Seize Cannabis Recreational Market

VANCOUVER, BC, March 28, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) Invictus MD is pleased to provide an update of its production capability in preparation for the recreational cannabis market. Marijuana could be legal in Canada by July 1, 2018;…

Invictus MD Announces Conditional Approval to List on the TSX Venture Exchange

On March 27, 2017, Posted by , In Investor Relations, With Comments Off on Invictus MD Announces Conditional Approval to List on the TSX Venture Exchange

VANCOUVER, BC, March 27, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) Invictus MD is pleased to announce it has received conditional approval to list its common shares for trading on the TSX Venture Exchange. Receiving the conditional listing approval from…

Invictus MD Appoints Global Strategic Leader to Board of Directors

On March 24, 2017, Posted by , In Investor Relations, With Comments Off on Invictus MD Appoints Global Strategic Leader to Board of Directors

VANCOUVER, BC, March 24, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) Invictus MD announced today that Mr. George E Kveton has been appointed to the Company’s Board of Directors. Mr. Kveton is a highly effective, strategic and pragmatic international executive…

Invictus MD’s AB Laboratories Inc. Provides Cultivation Update under ACMPR

On March 23, 2017, Posted by , In Investor Relations, With Comments Off on Invictus MD’s AB Laboratories Inc. Provides Cultivation Update under ACMPR

VANCOUVER, BC, March 23, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) Invictus MD announces that AB Laboratories Inc. (“AB Labs”) has successfully completed several test crops in its licensed production facility under the Access to Cannabis for Medical Purposes Regulations…

Invictus MD Announces Completion of its Commitment to Acquire 33.33% of Licensed Producer AB Laboratories Inc.

On March 14, 2017, Posted by , In Investor Relations, With Comments Off on Invictus MD Announces Completion of its Commitment to Acquire 33.33% of Licensed Producer AB Laboratories Inc.

VANCOUVER, BC, March 14, 2017 – INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that it has completed its final commitment with a cash transaction of CAD$2,000,000 to acquire 33.33% of AB Laboratories Inc. (“AB Labs”), a Licensed Producer…